24 novel compounds derived by cardanol were rationally designed and synthesized.
Their inhibitory activities against CHE were assessed and IC50 (μM) determined.
Font">26 showed potency against AChE, low cytotoxicity and capability to cross BBB.
This might be a first step towards innovative and sustainable new medicines for AD.